Literature DB >> 6393724

Recovery of the hypothalamus-pituitary-adrenal axis after short term high dose corticosteroid treatment in neurosurgical practice.

P Hedner, G Kullberg, I Bostedt.   

Abstract

The recovery of the hypothalamus-pituitary-adrenal axis after high-dose short-term steroid treatment was investigated in 18 patients undergoing stereotactic thalamotomy during local anaesthesia, in whom perioperative betamethasone was given in a high dose for 4-5 days and withdrawn without tapering. There were no untoward clinical effects of the abrupt withdrawal of the steroid. Seven patients undergoing the same operation without steroid treatment served as controls. The recovery of the hypothalamus-pituitary-adrenal axis after steroid treatment was studied by basal plasma cortisol levels. In 12 patients the reserve capacity of the system was investigated by the cortisol response to insulin induced hypoglycemia as well. It was found that the basal plasma cortisol levels had normalized 2 days after the abrupt withdrawal of betamethasone. In spite of normalized basal cortisol levels the capacity to respond to stress was reduced for a further 3 days. Six to seven days after the steroid withdrawal the stress response was, however, completely restored. It is concluded that high dose, short term steroid treatment can be withdrawn abruptly, omitting the usual tapering of the dose. During the first week after steroid withdrawal the cortisol response to stress is reduced even in the presence of normal basal cortisol levels. During this period extra corticosteroids must be supplied in case of an emergency situation or an operation.

Entities:  

Mesh:

Substances:

Year:  1984        PMID: 6393724     DOI: 10.1007/BF01400849

Source DB:  PubMed          Journal:  Acta Neurochir (Wien)        ISSN: 0001-6268            Impact factor:   2.216


  16 in total

1.  A simple fluorimetric method for the estimation of free 11-hydroxycorticoids in human plasma.

Authors:  D MATTINGLY
Journal:  J Clin Pathol       Date:  1962-07       Impact factor: 3.411

2.  Potency and duration of action of glucocorticoids. Effects of hydrocortisone, prednisone and dexamethasone on human pituitary-adrenal function.

Authors:  A W Meikle; F H Tyler
Journal:  Am J Med       Date:  1977-08       Impact factor: 4.965

Review 3.  Drug spotlight program: systemic corticosteroid therapy: pharmacology and endocrinologic considerations.

Authors:  J C Melby
Journal:  Ann Intern Med       Date:  1974-10       Impact factor: 25.391

4.  The adrenocortical response to craniotomy for brain tumor.

Authors:  H A Shenkin; P Gutterman; W F Bouzarth
Journal:  J Neurosurg       Date:  1971-05       Impact factor: 5.115

5.  Tests of hypothalamic-pituitary-adrenal function in man.

Authors:  H S Jacobs; J D Nabarro
Journal:  Q J Med       Date:  1969-10

6.  Adrenal suppression after short-term corticosteroid therapy.

Authors:  K S Wilson; A C Parker
Journal:  Lancet       Date:  1979-05-12       Impact factor: 79.321

7.  High-dose dexamethasone and adrenal function.

Authors:  H Olsson; L Brandt; M Telenius-Berg
Journal:  Lancet       Date:  1979-06-23       Impact factor: 79.321

8.  Pituitary adrenal recovery following short-term suppression with corticosteroids.

Authors:  W F Streck; D H Lockwood
Journal:  Am J Med       Date:  1979-06       Impact factor: 4.965

9.  The insulin tolerance test after pre-treatment with dexamethasone.

Authors:  P O Osterman; L Wide
Journal:  Acta Endocrinol (Copenh)       Date:  1976-10

10.  Endocrine response to substitution of corticotrophin for oral prednisolone in asthmatic children.

Authors:  D N Malone; J C Drever; I W Grant; I W Percy-Robb
Journal:  Br Med J       Date:  1972-07-22
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.